Cite
HARVARD Citation
Reich, K. et al. (2020). A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate‐to‐severe plaque psoriasis naive to systemic treatment. British journal of dermatology. pp. 869-879. [Online].